Xülasə Əsaslar Tərif Epidemiologiya etiologiya Patoziologiya
Yüklə 1,19 Mb. Pdf görüntüsü
|
- Bu səhifədəki naviqasiya:
- Qrip infeksiyası İstinad edilən materiallar
Qrip infeksiyası İstinad edilən materiallar İSTİNAD EDİLƏN MATERİALLAR 39. Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal inuenza with vaccines: recommendations of the Advisory Committee on Immunization Practices - United States, 2016-17 inuenza season. MMWR Morb Mortal Wkly Rep. 2016;65:1-54. Tam mətn
Abstrakt 40. Englund JA, Walter E, Black S, et al. Safety and immunogenicity of trivalent inactivated inuenza vaccine in infants: a randomized double-blind placebo-controlled study. Pediatr Infect Dis J. 2010;29:105-110. Abstrakt 41. Robinson CL; Advisory Committee on Immunization Practices (ACIP), ACIP Child/Adolescent Immunization Work Group. Advisory Committee on Immunization Practices recommended immunization schedules for persons aged 0 through 18 years - United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:86-87. Tam mətn
Abstrakt 42. Nolan T, Roy-Ghanta S, Montellano M, et al. Relative ecacy of AS03-adjuvanted pandemic inuenza A (H1N1) vaccine in children: results of a controlled, randomized ecacy trial. J Infect Dis. 2014;210:545-557. Tam mətn
Abstrakt 43. Kelso JM, Greenhawt MJ, Li JT, et al. Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol. 2012;130:25-43. Abstrakt 44. Wilde JA, McMillan JA, Serwint J, et al. Eectiveness of inuenza vaccine in health care professionals: a randomized trial. JAMA. 1999;281:908-913. Tam mətn
Abstrakt 45. Bridges CB, Thompson WW, Meltzer MI, et al. Eectiveness and cost-benet of inuenza vaccination of healthy working adults: a randomized controlled trial. JAMA. 2000;284:1655-1663. Tam mətn
Abstrakt 46. Nichol KL, Mendelman PM, Mallon KP, et al. Eectiveness of live, attenuated intranasal inuenza virus vaccine in healthy, working adults: a randomized controlled trial. JAMA. 1999;282:137-144. Tam mətn
Abstrakt 47. Edwards KM, Dupont WD, Westrich MK, et al. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of inuenza A disease. J Infect Dis. 1994;169:68-76. Abstrakt 48. Ohmit SE, Victor JC, Rottho JR, et al. Prevention of antigenically drifted inuenza by inactivated and live attenuated vaccines. N Engl J Med. 2006;355:2513-2522. Tam mətn
Abstrakt 49. DiazGranados CA, Denis M, Plotkin S. Seasonal inuenza vaccine ecacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine. 2012;31:49-57. Tam mətn
Abstrakt 50. Manzoli L, Ioannidis JP, Flacco ME, et al. Eectiveness and harms of seasonal and pandemic inuenza vaccines in children, adults and elderly: a critical review and re-analysis of 15 meta-analyses. Hum Vaccin Immunother. 2012;8:851-862. Tam mətn
Abstrakt 51. Osterholm MT, Kelley NS, Sommer A, et al. Ecacy and eectiveness of inuenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:36-44. Abstrakt 50 BMJ Qabaqcıl Praktika mövzusunun bu PDF sənədi ən son olaraq yenilənmiş internet variantına əsaslanır: Nov 30, 2017. BMJ Qabaqcıl Praktika mövzuları müntəzəm olaraq yenilənir və mövzuların ən son variantı buradan əldə edilə bilər bestpractice.bmj.com .Bu məzmunun istifadəsi bizim qaydalara müvaqdir İmtina. © © BMJ Publishing Group Ltd 2018. Bütün hüquqlar qorunur.
Qrip infeksiyası İstinad edilən materiallar 52. Ambrose CS, Wu X, Knuf M, et al. The ecacy of intranasal live attenuated inuenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies. Vaccine. 2012;30:886-892. Tam mətn
Abstrakt 53. Gorse GJ, Falsey AR, Ozol-Godfrey A, et al. Safety and immunogenicity of a quadrivalent intradermal inuenza vaccine in adults. Vaccine. 2015;33:1151-1159. Abstrakt 54. De Villiers PJ, Steele AD, Hiemstra LA, et al. Ecacy and safety of a live attenuated inuenza vaccine in adults 60 years of age and older. Vaccine. 2009;28:228-234. Abstrakt 55. Armstrong BG, Mangtani P, Fletcher A, et al. Eect of inuenza vaccination on excess deaths occurring during periods of high circulation of inuenza: cohort study in elderly people. BMJ. 2004;329:660. Tam mətn
Abstrakt 56. Cools HJ, Gussekloo J, Remmerswaal JE, et al. Benets of increasing the dose of inuenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial. J Med Virol. 2009;81:908-914. Abstrakt 57. DiazGranados CA, Dunning AJ, Kimmel M, et al. Ecacy of high-dose versus standard-dose inuenza vaccine in older adults. N Engl J Med. 2014;371:635-645. Tam mətn
Abstrakt 58. Nace DA, Lin CJ, Ross TM, et al. Randomized, controlled trial of high-dose inuenza vaccine among frail residents of long-term care facilities. J Infect Dis. 2015;211:1915-1924. Tam mətn
Abstrakt 59. Lehmann HC, Hartung HP, Kieseier BC, et al. Guillain-Barré syndrome after exposure to inuenza virus. Lancet Infect Dis. 2010;10:643-651. Abstrakt 60. Lasky T, Terracciano GJ, Magder L, et al. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 inuenza vaccines. N Engl J Med. 1998;339:1797-1802. Abstrakt 61. Centers for Disease Control and Prevention (CDC). Inuenza signs and symptoms and the role of laboratory diagnostics. October 2016. http://www.cdc.gov (last accessed 9 March 2017). Tam mətn 62. Call SA, Vollenweider MA, Hornung CA, et al. Does this patient have inuenza? JAMA. 2005;293:987-997. Abstrakt 63. Hayden FG, Fritz R, Lobo MC, et al. Local and systemic cytokine responses during experimental human inuenza A virus infection. Relation to symptom formation and host defense. J Clin Invest. 1998;101:643-649. Tam mətn
Abstrakt 64. Monto AS, Gravenstein S, Elliott M, et al. Clinical signs and symptoms predicting inuenza infection. Arch Intern Med. 2000;160:3243-3247. Tam mətn
Abstrakt 65. Nicholson KG, Kent J, Hammersley V, et al. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. BMJ. 1997;315:1060-1064. Tam mətn
Abstrakt 66. Vesikari T, Beran J, Durviaux S, et al. Use of real-time polymerase chain reaction (rtPCR) as a diagnostic tool for inuenza infection in a vaccine ecacy trial. J Clin Virol. 2012;53:22-28. Abstrakt İSTİNAD EDİLƏN MATERİALLAR BMJ Qabaqcıl Praktika mövzusunun bu PDF sənədi ən son olaraq yenilənmiş internet variantına əsaslanır: Nov 30, 2017. BMJ Qabaqcıl Praktika mövzuları müntəzəm olaraq yenilənir və mövzuların ən son variantı buradan əldə edilə bilər bestpractice.bmj.com .Bu məzmunun istifadəsi bizim qaydalara müvaqdir İmtina. © © BMJ Publishing Group Ltd 2018. Bütün hüquqlar qorunur. 51
Yüklə 1,19 Mb. Dostları ilə paylaş:
|